Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyJean‐Paul Viard, Amanda Mocroft, Jean‐Claude Souberbielle et al.|AIDS|2011Cited by 192
Changes in use of antiretroviral therapy in regions of Europe over timeOle Kirk, Jens Lundgren, Amanda Mocroft et al.|AIDS|1998Cited by 64
Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected PersonsLeah Shepherd, J.C. Souberbielle, J.-P. Bastard et al.|The Journal of Infectious Diseases|2014Cited by 54
The cardiovascular risk management for people living with HIV in EuropeMaryam Shahmanesh, Amanda Mocroft, Anna Schultze et al.|AIDS|2016Cited by 30
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Johan Iversen, Caroline Sabin et al.|Open Forum Infectious Diseases|2016Cited by 29